Late Vitreoretinal Complications of Regressed Retinopathy of Prematurity: Retinal Break, Vitreous Hemorrhage, and Retinal Detachment.


Journal

Ophthalmology. Retina
ISSN: 2468-6530
Titre abrégé: Ophthalmol Retina
Pays: United States
ID NLM: 101695048

Informations de publication

Date de publication:
01 2023
Historique:
received: 26 02 2022
revised: 07 07 2022
accepted: 08 07 2022
pubmed: 18 7 2022
medline: 10 1 2023
entrez: 17 7 2022
Statut: ppublish

Résumé

To investigate late vitreoretinal complications and visual outcomes in patients with regressed retinopathy of prematurity (ROP) with or without prior treatment. International, multicenter, noncomparative retrospective case series. We analyzed 264 eyes of 238 patients from 13 centers worldwide who developed vitreoretinal complications (retinal detachment [RD], vitreous hemorrhage [VH], or retinal break) ≥ 2 years after resolution of acute ROP. Each participant was assigned to 1 of 3 groups (the RD, VH, and retinal break groups) according to their primary diagnosis. The average age at presentation, visual acuities, refractive error, axial length, gestational age, birth weight, acute ROP classification, prior treatments for acute ROP, postoperative visual acuity (VA), and concomitant eye conditions in the 3 groups were documented and compared. Clinical features and visual outcomes of late vitreoretinal complications in patients with regressed ROP. A total of 264 eyes of 238 patients were included. The prior acute ROP status was comparable among the 3 groups, except that the VH group had a higher proportion of patients with type 1 ROP (P = 0.03) and prior treatment (P < 0.001) than the other groups. The average age at presentation was earlier in the RD (20.3 ± 15.5 years) and VH (21.4 ± 18.9 years) groups than in the retinal break group (31.9 ± 18.2 years; P < 0.001). The retinal break group had the best presenting best-corrected VA, followed by the RD and VH groups (P < 0.001). Surgical intervention improved VA in both the RD and VH groups (both P < 0.05). The overall trend of VA was the most favorable in the retinal break group, followed by that in the VH and RD groups. Cicatricial changes in the fellow retina were observed in > 90% of patients with unilateral involvement. Infants with acute ROP remain at a high risk of vision-threatening complications throughout childhood and adulthood. Continual follow-up of patients with ROP is important. When severe complications, such as RD or VH, are detected, timely surgical intervention is necessary to ensure favorable visual outcomes in these patients.

Identifiants

pubmed: 35843486
pii: S2468-6530(22)00342-6
doi: 10.1016/j.oret.2022.07.005
pii:
doi:

Types de publication

Multicenter Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

72-80

Subventions

Organisme : NEI NIH HHS
ID : P30 EY006360
Pays : United States

Informations de copyright

Copyright © 2022 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Auteurs

Han-Tung Hsu (HT)

Department of Ophthalmology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.

Eugene Yu-Chuan Kang (E)

Department of Ophthalmology, Chang Gung Memorial Hospital, Taoyuan, Taiwan; College of Medicine, Chang Gung University, Taoyuan, Taiwan.

Michael P Blair (MP)

Retina Consultants Ltd., Des Plaines, Illinois.

Michael Shapiro (M)

Retina Consultants Ltd., Des Plaines, Illinois.

Rahul Komati (R)

Retina Consultants Ltd., Des Plaines, Illinois.

Baker G Hubbard (BG)

Emory University School of Medicine, Atlanta, Georgia.

Kenneth W Price (KW)

Emory University School of Medicine, Atlanta, Georgia.

Antonio Capone (A)

Associated Retinal Consultants, Royal Oak, Michigan.

Kim A Drenser (KA)

Associated Retinal Consultants, Royal Oak, Michigan.

Michael T Trese (MT)

Associated Retinal Consultants, Royal Oak, Michigan.

Ryan Shields (R)

Associated Retinal Consultants, Royal Oak, Michigan.

Hiroyuki Kondo (H)

Department of Ophthalmology, University of Occupational and Environmental Health, Fukuoka, Japan.

Itsuka Matsushita (I)

Department of Ophthalmology, University of Occupational and Environmental Health, Fukuoka, Japan.

Yoshihiro Yonekawa (Y)

Wills Eye Hospital, Mid Atlantic Retina, Thomas Jefferson University, Philadelphia, Pennsylvania.

Samir N Patel (SN)

Wills Eye Hospital, Mid Atlantic Retina, Thomas Jefferson University, Philadelphia, Pennsylvania.

Shunji Kusaka (S)

Department of Ophthalmology, Kindai University Faculty of Medicine, Osaka, Japan.

Fukutaro Mano (F)

Department of Ophthalmology, Kindai University Faculty of Medicine, Osaka, Japan.

Karl R Olsen (KR)

Retina Vitreous Consultants, Monroeville, Pennsylvania.

Anna Ells (A)

Calgary Retina Consultants, Southern Alberta Eye Center, Alberta, Canada.

Atchara Amphornphruet (A)

Rajavithi Hospital, Ministry of Public Health, College of Medicine, Rangsit University, Thailand.

Mark K Walsh (MK)

Retina Associates, Tucson, Arizona.

Cagri G Besirli (CG)

Kellogg Eye Center, University of Michigan School of Medicine, Ann Arbor, Michigan.

Omar Moinuddin (O)

Kellogg Eye Center, University of Michigan School of Medicine, Ann Arbor, Michigan.

Caroline R Baumal (CR)

New England Eye Center, Tufts Medical Center, Boston, Massachusetts.

Ana Bety Enriquez (AB)

New England Eye Center, Tufts Medical Center, Boston, Massachusetts.

Yih-Shiou Hwang (YS)

Department of Ophthalmology, Chang Gung Memorial Hospital, Taoyuan, Taiwan; College of Medicine, Chang Gung University, Taoyuan, Taiwan.

Chi-Chun Lai (CC)

Department of Ophthalmology, Chang Gung Memorial Hospital, Taoyuan, Taiwan; College of Medicine, Chang Gung University, Taoyuan, Taiwan.

Wei-Chi Wu (WC)

Department of Ophthalmology, Chang Gung Memorial Hospital, Taoyuan, Taiwan; College of Medicine, Chang Gung University, Taoyuan, Taiwan. Electronic address: weichi666@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH